Aehr Test Systems’ EVP Consistently Offloads Shares Amid Stubborn Low P/E, Investors Urged to Watch Volatility Flare.

Insider Selling Continues to Shake Aehr Test Systems

The most recent filing on January 14, 2026 shows Executive Vice President of Sales & Marketing, Roger Vernon, selling 464 shares of Aehr Test Systems common stock at $25.97 a share. The sale reduces his holding to 177,366 shares, roughly 0.02 % of the outstanding equity. While the transaction itself is modest in absolute terms, it follows a pattern of frequent, small‑scale sales that have been consistent over the past months.

Implications for Investors

Vernon’s trading cadence—selling roughly 100–600 shares weekly at market price—signals a short‑term liquidity need rather than a change in long‑term confidence. The stock has been on a bullish run, up 7.40 % in the past week and 13.31 % in the month, and sits near a 52‑week low. A negative P/E of –75.78 underscores that the company’s earnings remain weak, so insider outflows may be viewed as a risk factor. If the trend continues, it could weigh on price momentum and increase volatility for shareholders who are sensitive to insider sentiment.

What This Means for the Company’s Future

The steady stream of insider sales, coupled with a positive social‑media buzz of 210 % and a sentiment score of +16, suggests that market participants are aware of the activity but remain largely neutral or slightly optimistic. The company’s focus on memory‑testing equipment—an essential component for DRAM manufacturers—provides a durable revenue stream, but profitability remains a challenge. Unless the management team can accelerate earnings growth or improve operational efficiency, the negative P/E may persist, keeping the stock vulnerable to insider‑driven price swings.

Profile: Roger Vernon – A Consistent Seller

Vernon has executed at least 18 insider transactions since September 2025, with the majority being sales. His trades typically occur at market prices ranging from $6.67 to $32.25, reflecting a strategy of selling in small blocks rather than large, market‑disruptive moves. He has also purchased shares in October 2025 (e.g., 1,330 shares at $6.67), indicating that he is still invested in the company’s long‑term prospects. His trading pattern—regular, low‑volume sales interspersed with occasional purchases—suggests a liquidity‑driven approach rather than a signal of declining confidence.

Bottom Line

For investors, Vernon’s latest sale is a footnote in a broader trend of insider liquidity management. While it does not necessarily spell trouble for Aehr Test Systems, it should prompt a closer look at the company’s earnings trajectory and cash flow generation. The combination of a high social‑media buzz and a negative P/E ratio means that even small insider movements can trigger outsized market reactions, so staying informed about future filings will be key to navigating the stock’s current volatility.